Key Developments: Teleflex Inc (TFX.N)
78.30USD
23 May 2013
$0.32 (+0.41%)
$77.98
$77.53
$78.61
$77.49
62,979
72,884
$87.45
$57.28
Latest Key Developments (Source: Significant Developments)
Teleflex Inc Raises FY 2012 Revenue Guidance; Narrows FY 2012 EPS Guidance To A Range In Line With Analysts' Estimates
Teleflex Inc announced that it is updating its guidance ranges for constant currency revenue growth and adjusted earnings per share. The Company now expect to generate constant currency revenue growth of between 6% and 7%, and adjusted earnings per share of between $4.35 and $4.40. The Company reported revenues of $1.529 billion in fiscal 2011. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.539 billion and EPS of $4.36 for fiscal 2012. Full Article
Teleflex Inc Signs New Agreements With Premier For Endotracheal Products
Teleflex Inc announced that is has been awarded two new three-year group purchasing agreements for endotracheal tubes and related products with the Premier healthcare alliance. The two agreements, one of which is offered through Premier`s ASCEND collaborative, are effective January 1, 2013 through December 31, 2015. Through these agreements, Premier`s alliance of 2,700 hospitals will have access to a complete line of Rusch and Sheridan endotracheal tubes, including the ISIS HVT endotracheal tubes, and related products at exclusive member rates. Full Article
Teleflex Inc Receives FDA Clearance For ARROW Peripherally Inserted Central Catheter (PICC) Preloaded With ARROW VPS Vascular Positioning System Stylet
Teleflex Inc announced it has received FDA 510(k) clearance to market its pressure injectable ARROW PICC preloaded with the ARROW VPS Vascular Positioning System Stylet. The ARROW VPS replaces the need for confirmatory chest X-ray in the presence of a stable Blue Bullseye by using real-time intravascular Doppler, ECG and advanced algorithmic logic to notify the clinician that the catheter tip has reached the optimal location. The preloaded option improves clinician ease of use for vascular navigation and catheter tip positioning. Full Article
Teleflex Inc Secures Technology Agreement From Novation For ARROW VPS Vascular Positioning System Products
Teleflex Inc announced that it has been awarded a three-year technology agreement with Novation for the ARROW VPS Vascular Positioning System. This agreement includes the VPS console, stylets and pre-loaded stylets and is effective September 1, 2012 through August 31, 2015. Full Article
Teleflex Inc Reaffirms FY 2012 Revenue Guidance-Conference Call
Teleflex Inc. reaffirmed fiscal 2012 guidance for constant currency revenue growth and expects revenue growth between 4% and 6%.The Company reported revenues of $1.529 billion in fiscal 2011. Full Article
Teleflex Inc Secures New Premier Agreement For Comprehensive Respiratory Line
Teleflex Inc announced it has been awarded a new group purchasing agreement to supply its comprehensive line of respiratory products with the Premier healthcare alliance. The three year multi-source agreement is effective November 1, 2012 and extends through October 31, 2015. Through this agreement, Premier’s alliance of 2,600 hospitals will have access to the complete Teleflex respiratory line at exclusive member rates, which includes aerosol and medication delivery, oxygen therapy and ventilation management. Well-established Hudson RCI, Gibeck and Rusch products, versatile devices such as the ConchaTherm Neptune Heated Humidifier, and clinical education programs are also included. Full Article
Teleflex Inc Completes Sale of OEM Orthopedics Business
Teleflex Inc announced that it has completed the previously announced sale of its OEM Orthopedics business to Tecomet. The OEM Orthopedics business is reflected as a discontinued operation in Teleflex's consolidated financial statements. Ballard Spahr LLP acted as legal counsel to Teleflex in the transaction. Full Article
Teleflex Inc Signs Definitive Agreement to Acquire Assets of LMA International N.V.
Teleflex Inc announced it signed a definitive agreement to acquire substantially all of the assets of LMA International N.V. for SGD343.5 million in cash, which at current exchange rates translates into approximately $276 million. LMA is a company in laryngeal masks with a portfolio of products used in anesthesia and emergency care. The Board of Directors of both Teleflex and LMA have approved the proposed transaction. The transactions are expected to be completed during the fourth quarter of 2012. Full Article
Teleflex Inc. Announces Quarterly Dividend
Teleflex Inc. announced that its Board of Directors declared a quarterly cash dividend of $0.34 per share of common stock. The dividend is payable September 14, 2012 to shareholders of record at the close of business on August 15, 2012. Full Article
Teleflex Inc. Reaffirms FY 2012 Guidance
Teleflex Inc. reaffirmed fiscal 2012 guidance for constant currency revenue growth and adjusted EPS ranges. The Company expects constant currency revenue growth between 4% and 6% and adjusted earnings per share (EPS) in the range of $4.25 to $4.45. The Company reported revenues of $1.528 billion in fiscal 2011. According to I/B/E/S estimates, analysts were expecting the Company to report revenue of $1.58 billion and EPS of $4.36 for fiscal 2012. Full Article

Earnings vs.
Estimates